BlackRock Amends Vericel Stake: Passive Investment Update
Ticker: VCEL · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 887359
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in Vericel, signaling a minor portfolio adjustment.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 22, 2024, indicating a change in its ownership of Vericel Corp's common stock as of December 31, 2023. This filing, Amendment No. 6, shows BlackRock's updated passive investment stake in Vericel, a biological products company. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in confidence or strategy regarding Vericel's future performance.
Why It Matters
This filing updates BlackRock's passive ownership in Vericel, providing transparency on a significant institutional investor's position, which can influence market perception and trading activity.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk or opportunity.
Analyst Insight
Investors should note BlackRock's continued passive interest in Vericel, but this filing alone doesn't suggest a need for immediate action, as it's a routine update of a passive stake.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Vericel Corp (company) — the subject company whose common stock is being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 6 (number) — the specific amendment number of the filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'Amendment No: 6' in the filing.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as stated under '(1)Names of reporting persons. BlackRock, Inc.' in the filing.
What is the subject company whose securities are being reported?
The subject company is Vericel Corp, as clearly stated under '(Name of Issuer) Vericel Corp' and in the 'SUBJECT COMPANY' section of the filing.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of Vericel Corp is 92346J108, as listed under '(CUSIP Number) 92346J108' in the filing.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement) December 31, 2023'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding Vericel Corp (VCEL).